+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07060716

Study to Validate Donor-Derived Cell-Free DNA Test for Monitoring Kidney Transplant Rejection

Led by Insight Molecular Diagnostics · Updated on 2025-11-19

125

Participants Needed

10

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the donor-derived cell-free DNA dd-cfDNA test to see if it can effectively identify rejection in kidney transplant recipients. This observational study compares the results of the GraftAssureDx dd-cfDNA test with rejection confirmed by standard graft biopsies. The goal is to validate the dd-cfDNA test as a reliable tool for monitoring kidney transplant health. Participants will have blood and urine samples collected during their study visits. The dd-cfDNA test measures the amount and proportion of donor-derived cell-free DNA in the blood. Samples will be analyzed from enrollment up to 24 weeks after collection to assess the tests clinical performance against biopsy results. The study involves no treatment but focuses on diagnostic assessment. During the study, participants will provide blood and urine samples and undergo graft biopsies within a week of the blood draw to compare results. Researchers will also monitor traditional kidney rejection biomarkers such as creatinine and blood urea nitrogen. The study will track these measures over 18 to 24 weeks after sample collection. Participants are followed to assess the accuracy and reliability of the dd-cfDNA test in detecting rejection, with no intervention or treatment changes required during the study period.

CONDITIONS

Brief Title

Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

Research Team

R

Robert Rogers, M.S.

E

Ekkehard Schuetz, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here